Reducing marginal B cell subsets in other patients with antibody production defects could be associated with an increased risk of infection such as pneumonia and a decrease in serum IgM levels, similar to CVID patients [35]. The gene discussed is CD40LG; the disease is susceptibility to pneumonia measurement.